Resveratrol transport and metabolism by human intestinal Caco-2 cells
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Resveratrol is a dietary constituent suggested to have protective effects against cancer as well as cardiovascular disease. The purpose of the study was to learn whether this agent could be absorbed in man and enter the systemic circulation. This was examined by measuring transport and metabolism of resveratrol (5–40 μM) by the human intestinal epithelial cell line Caco-2 cultured in Transwells. Transport across the Caco-2 monolayer occurred in a direction-independent manner with Papp values of ≅ 7 times 10−6 cm s−1, much higher than for the paracellular transport marker mannitol (≅ 0.4 times 10−6 cms−1), suggesting efficient absorption in-vivo. At the highest resveratrol concentration, the absorption increased, possibly due to saturation of metabolism. In sharp contrast to previous findings in the rat, the metabolism of resveratrol in Caco-2 cells involved mainly sulfation and, to a minor extent, glucuronidation. At low resveratrol concentrations, most of the sulfate conjugate was exported to the apical side, presumably by MRP2, which is well expressed in these cells. At high concentrations, there was a shift towards the basolateral side, possibly involving MRP3, which was recently shown also to be expressed in Caco-2 cells. These results indicate that absorption of resveratrol in-vivo may be high but with limited bioavailability due to efficient sulfate conjugation. Extensive accumulation of resveratrol in the Caco-2 cells, demonstrated in additional experiments, suggests enterocytes as a major target site for this cancer preventive agent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W. W., Fong, H. H. S., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., et al. (1997) · Science · doi:10.1126/science.275.5297.218 · Cited by 4,935 · cited 2×
“Introduction Resveratrol is a naturally-occurring polyphenolic compound with a distinct chemical structure (Figure 1), which has received much attention for its potential preventive actions in human disease (Jang et al 1997; Fre mont 2000; Gusman et al 2001; Wu et al 2001).”
Background
Cited by
HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., & Walle, U. K. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000885 · Cited by 1,880
Self-citationBioavailability of resveratrol
Walle, T. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05842.x · Cited by 1,051
Self-citationResveratrol as an anti-inflammatory and anti-aging agent: Mechanisms and clinical implications
Alarcón de la Lastra, C., & Villegas, I. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500022 · Cited by 703
Metabolism and bioavailability oftrans-resveratrol
Wenzel, E., & Somoza, V. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500010 · Cited by 676
Administration of resveratrol: What formulation solutions to bioavailability limitations?
Amri, A., Chaumeil, J. C., Sfar, S., & Charrueau, C. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.083 · Cited by 620
Resveratrol (RV): A pharmacological review and call for further research
Zhang, L.-X., Li, C.-X., Kakar, M. U., Khan, M. S., Wu, P.-F., Amir, R. M., Dai, D.-F., Naveed, M., Li, Q.-Y., Saeed, M., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112164 · Cited by 546
Resveratrol and cancer: focus on in vivo evidence
Carter, L. G., D'Orazio, J. A., & Pearson, K. J. (2014) · Endocrine-Related Cancer · doi:10.1530/erc-13-0171 · Cited by 522
Resveratrol as an anticancer nutrient: molecular basis, open questions and promises
Signorelli, P., & Ghidoni, R. (2005) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2005.01.017 · Cited by 489
Resveratrol: French Paradox Revisited
Catalgol, B., Batirel, S., Taga, Y., & Ozer, N. K. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00141 · Cited by 449
“Also the actions of resveratrol were found to be related to its 3-O-sulfate (predominantly) and 3-O-beta-d-, 4′-O-betad-glucuronide metabolites (Kaldas et al., 2003).”
BackgroundResveratrol: Its Biologic Targets and Functional Activity
Pervaiz, S., & Holme, A. L. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2412 · Cited by 405
Phenolic compounds: their journey after intake
Velderrain-Rodríguez, G. R., Palafox-Carlos, H., Wall-Medrano, A., Ayala-Zavala, J. F., Chen, C.-Y. O., Robles-Sánchez, M., Astiazaran-García, H., Alvarez-Parrilla, E., & González-Aguilar, G. A. (2014) · Food Funct. · doi:10.1039/c3fo60361j · Cited by 399
Methylated Flavonoids Have Greatly Improved Intestinal Absorption and Metabolic Stability
Wen, X., & Walle, T. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.011122 · Cited by 377
Self-citationQiao, Y., Sun, J., Xia, S., Tang, X., Shi, Y., & Le, G. (2014) · Food & Function · doi:10.1039/c3fo60630a · Cited by 367
Pharmacometrics of Stilbenes: Seguing Towards the Clinic
Roupe, K., Remsberg, C., Yanez, J., & Davies, N. (2006) · Current Clinical Pharmacology · doi:10.2174/157488406775268246 · Cited by 309
Wu, B., Kulkarni, K., Basu, S., Zhang, S., & Hu, M. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22568 · Cited by 309
King, R. E., Bomser, J. A., & Min, D. B. (2006) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/j.1541-4337.2006.00001.x · Cited by 289
Resveratrol for breast cancer prevention and therapy: Preclinical evidence and molecular mechanisms
Sinha, D., Sarkar, N., Biswas, J., & Bishayee, A. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.11.001 · Cited by 258
Bioavailability challenges associated with development of anti-cancer phenolics
Gao, S., & Hu, M. (2010) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955710791384081 · Cited by 242
Overview of metabolism and bioavailability enhancement of polyphenols
Lewandowska, U., Szewczyk, K., Hrabec, E., Janecka, A., & Gorlach, S. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf404439b · Cited by 196
Resveratrol: Challenges in Translation to the Clinic — A Critical Discussion
Subramanian, L., Youssef, S., Bhattacharya, S., Kenealey, J., Polans, A. S., & van Ginkel, P. R. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1486 · Cited by 103
Delipidating effect of resveratrol metabolites in 3 T 3‐L 1 adipocytes
Lasa, A., Churruca, I., Eseberri, I., Andrés‐Lacueva, C., & Portillo, M. P. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100772 · Cited by 103
“For instance, it has been reported that the plasma concentration of this polyphenol after a dietarily relevant 25 mg oral dose of resveratrol is only in the nanomolar range compared with the micromolar range of its metabolites [17, 21, 22].”
BackgroundRole of Drug Delivery System in Improving the Bioavailability of Resveratrol
Saleem, Z., Rehman, K., & Hamid Akash, M. S. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220705113514 · Cited by 34
Resveratrol promotes degradation of the human bile acid transporter ASBT (SLC10A2)
Chothe, P. P., & Swaan, P. W. (2014) · Biochemical Journal · doi:10.1042/bj20131428 · Cited by 29
Resveratrol and Spirulina: Nutraceuticals that potentially improving cardiovascular disease
Wang, Y., Ocampo, M. F., Rodriguez, B., & Chen, J. (2020) · Journal of Cardiovascular Medicine and Cardiology · doi:10.17352/2455-2976.000129 · Cited by 8
Metadata
- Authors
- Kaldas, M. I., Walle, U. K., & Walle, T.
- Venue
- Journal of Pharmacy and Pharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-03-01
- Volume
- 55
- Issue
- 3
- Pages
- 307-312
- ISSN
- 0022-3573 (ISSN-L)
- 2042-7158
- OpenAlex
- W2011355924
- Cited by
- 188
- References
- 1
- FWCI
- 4.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.